CCN4/WISP-1 and CCN5/WISP-2 have roles in metabolic disorders involving glucose homeostasis, such as insulin resistance, diabetes, and obesity [16,32,33], and have been associated with the development and regulation of different types of cancers [34,35,36]. This evidence concerns the gene CCN4 and obesity disorder.